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Abstract 
Previous research has suggested a possible role of serotonin in emotional expressions, such as 
crying. We have found that a transient increase of central serotonin levels by means of oral 
administration of paroxetine reduces crying in response to emotional movies in healthy 
female volunteers. This is the first direct evidence of an important role of serotonin in this 
uniquely human emotional response. 
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Crying is a uniquely human emotional response. The utility of crying for newborns is well 
established, but little is known about the functions, determinants, and consequences of crying 
in adults. Factors such as age, gender, attachment style, and  personality  (e.g., neuroticism 
and empathy) play a role, but little is known about the underlying neurobiological 
mechanisms1. It has been reported that pathological crying can be successfully treated with 
selective serotonin reuptake inhibitors (SSRIs), implicating serotonin as being a potential 
modulator of crying2. Furthermore, some studies have shown that tryptophan, which is the 
precursor of 5-HT, is reduced in women in the postpartum period3, which is characterized by 
emotional lability and a high crying proneness4. Finally, preliminary data suggest that being in 
love is accompanied by low 5-HT levels5. Together, this evidence suggests that 5-HT levels 
might influence the emotional threshold for crying. Therefore, we directly examined whether 
acute increases in central 5-HT levels by means of the SSRI paroxetine increases the crying 
threshold. 
 Twenty-five healthy female volunteers were tested in a double-blind randomized 
placebo-controlled single-dose cross-over design. Placebo or paroxetine (20 mg) were orally 
administered on two days, separated by a one-week interval. On both days, participants 
watched an emotional movie (either ‘Brian’s Song’ or ‘Once Were Warriors’) five hours after 
medication administration, the time at which the effect of paroxetine on central 5-HT levels is 
maximal6. Directly after the movie, the crying of the participants in response to a number of 
specific scenes was measured with a validated questionnaire7. In order to control for possible 
effects on mood and the evaluation of emotional stimuli, mood was measured directly before 
administration of the pill and after the movie by means of the profile of mood scales 
(POMS)8, whereas valence and arousal ratings were obtained using a subset of  the 
International Affective Pictures System9. Four categories of 10 pictures each were selected on 
the basis of their valence (high/low) and arousal (high/low) norm ratings. 
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 Analysis of variance showed that paroxetine strongly affected the intensity of self-
reported crying behavior (three-way interaction treatment x movie x order, F1,21 = 16.9, P < 
0.0005, η2=.446; Figure 1). A follow-up analysis showed that crying was reduced on the 
paroxetine day (T=3.97, P < .005).  
<<Insert Figure 1 about here>> 
 Paroxetine did not affect mood or overall appraisal of emotional pictures. Arousal and 
valence ratings of specific categories of the emotional pictures, however, were affected 
(arousal: treatment x high/low valence category, F1,21 = 7.6, P < 0.05, η2= 0.25; valence: 
treatment x high/low arousal category, F1,21 = 5.5, P < 0.05, η2= 0.19). More precisely, 
paroxetine decreased arousal ratings in the high arousal/low valence category and valence 
ratings of the high arousal/high valence category (see Figure 2). This raised the question 
whether the altered evaluation of specific subgroups of emotional stimuli could be responsible 
for the reduced crying response to the movies, observed in the paroxetine condition. To 
examine this, correlations between the ratings and crying were computed. It was found that 
the arousal score for the high arousal/low valence category in the paroxetine condition was 
significantly correlated with crying (r=.52, P<.01), with higher arousal scores going together 
with more crying. The valence scores in the high valence/high arousal category did not show 
an association with crying. A further analysis on individual differences revealed that 
paroxetine has a stronger inhibiting effect on the crying of women with high neuroticism 
scores (correlation between neuroticism scores and crying on paroxetine day, r=-.63, P < 
.001). No significant relation was found with romantic love, attachment style or sleep quality.  
<<Insert Figure 2 about here>> 
 The finding that paroxetine heightens the crying threshold clearly supports our 
hypothesis that 5-HT is involved in crying. However, this effect can partially be attributed to 
the changed appraisal of emotional stimuli. Although only the arousal ratings of a subgroup of 
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pictures were affected, the effect was in the expected direction and the affected category of 
pictures was most comparable to the movie scenes in terms of emotional content. In addition, 
arousal ratings were associated with crying behavior only on the paroxetine day. The effect of 
paroxetine on the evaluation of emotional pictures was not in line with the results of previous 
studies10, 11, which failed to show an effect of different SSRIs on valence ratings of emotional 
pictures. It should be noted, however, that these studies failed to differentiate between 
subcategories of pictures in terms of arousal.   
 The association between neuroticism and crying behavior corroborates  previous 
findings demonstrating a relation between 5-HT and neuroticism12.  Neuroticism has been 
associated with a polymorphism of the gene that regulates the 5-HT transporter, which is 
associated with higher central 5-HT levels and a greater anti-depressive response to 
paroxetine13. Therefore, it could be argued that among the participants with high neuroticism 
scores, on average the potential effect of paroxetine is larger, which could explain the found 
relation between neuroticism and crying behavior after paroxetine. 
 In conclusion, this is the first study that shows a direct relation between central 5-HT 
levels and crying behavior in healthy volunteers. This study shows that SSRIs can have a 
major effect on the expression of emotions, which can have serious consequences for both the 
measured and experienced treatment effects of SSRIs. Further research is necessary to show 
whether the role of 5-HT is restricted to crying behavior or whether it extends to other 
(including positive) emotional expressions as well. There is some evidence that suggests that 
5-HT also is involved in laughing14, but direct evidence in healthy volunteers is lacking. More 
research is also necessary to further elucidate the underlying neurophysiological processes 
and specify the precise role of 5-HT in this positive emotional expression. Taken together this 
would lead to a better insight into the underlying neurobiological mechanisms of this 
mysterious and important, but scientifically ignored and poorly understood human behavior.  
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Figure 1 Effect of paroxetine or placebo on subjective crying as expressed in z-scores for 
‘Once were Warriors’ presented as the first or second movie (warriors1, warriors2) and 
‘Brian’s song’ presented as first or second movie (Brian1, Brian2).  
 
-1
-0,5
0
0,5
1
1,5
warriors1 warriors2 brian1 brian2Su
bj
ec
tiv
e 
C
ry
in
g 
(z
-s
co
re
s)
paroxetine
placebo
 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
10
.5
13
6.
1 
: P
os
te
d 
27
 O
ct
 2
01
0
 
 
Figure 2 Scatter plot of subjective crying expressed in z-scores and arousal ratings as 
measured on a 9-point scale (r=.52, P<.01).  
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